Literature DB >> 14354009

The anemia of liver disease: observations on its mechanism.

J H JANDL.   

Abstract

Entities:  

Keywords:  ANEMIA; LIVER CIRRHOSIS/complications

Mesh:

Year:  1955        PMID: 14354009      PMCID: PMC438641          DOI: 10.1172/JCI103087

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  The effects of cortisone and adrenocorticotrophic hormone on dispersion of bruises in the skin.

Authors:  R R LOVELL; G B SCOTT; B HUDSON; J A OSBORNE
Journal:  Br J Exp Pathol       Date:  1953-10

2.  The influence of cortisone on the rate of blood absorption from the eye.

Authors:  W H BENEDICT; R W HOLLENHORST
Journal:  Am J Ophthalmol       Date:  1953-02       Impact factor: 5.258

3.  The limit of hemoglobin synthesis in hereditary hemolytic anemia; its relation to the excretion of bile pigment.

Authors:  W H CROSBY; J H AKEROYD
Journal:  Am J Med       Date:  1952-09       Impact factor: 4.965

4.  DISTRIBUTION OF ASCORBIC ACID IN THE BLOOD AND ITS NUTRITIONAL SIGNIFICANCE.

Authors:  A M Butler; M Cushman
Journal:  J Clin Invest       Date:  1940-05       Impact factor: 14.808

5.  EXPERIMENTAL AND CLINICAL OBSERVATIONS ON INCREASED MECHANICAL FRAGILITY OF ERYTHROCYTES.

Authors:  S C Shen; W B Castle; E M Fleming
Journal:  Science       Date:  1944-10-27       Impact factor: 47.728

6.  Potentiation of pteroylglutamic acid by ascorbic acid in anemia of scurvy.

Authors:  J H JANDL; G J GABUZDA
Journal:  Proc Soc Exp Biol Med       Date:  1953-11

7.  The tagging of red cells and plasma proteins with radioactive chromium.

Authors:  S J GRAY; K STERLING
Journal:  J Clin Invest       Date:  1950-12       Impact factor: 14.808

8.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

9.  Hemolytic anemia associated with liver disease.

Authors:  G A HYMAN; H SOUTHWORTH
Journal:  Am J Med Sci       Date:  1951-04       Impact factor: 2.378

10.  Vitamin B12 assay in body fluids using Euglena gracilis.

Authors:  G I M ROSS
Journal:  J Clin Pathol       Date:  1952-08       Impact factor: 3.411

View more
  52 in total

1.  [Agglutination of antibody-treated erythrocytes in dependence on the neuraminic acid content of the serum].

Authors:  H STICKL
Journal:  Klin Wochenschr       Date:  1959-06-01

2.  PLATELET SEQUESTRATION IN MAN. II. IMMUNOLOGICAL AND CLINICAL STUDIES.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

3.  INFLUENCE OF SPLEEN SIZE AND PORTAL PRESSURE ON ERYTHROCYTE SEQUESTRATION.

Authors:  R T HOLZBACH; R A SHIPLEY; R E CLARK; E B CHUDZIK
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

4.  SUPPRESSION HEMATOPOIESIS BY ETHANOL.

Authors:  L W SULLIVAN; V HERBERT
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

5.  FOLIC ACID DEFICIENCY IN CIRRHOSIS OF THE LIVER.

Authors:  D J DELLER; C L KIMBER; R N IBBOTSON
Journal:  Am J Dig Dis       Date:  1965-01

6.  MEGALOBLASTIC ANAEMIA IN HAEMOCHROMATOSIS.

Authors:  P J TOGHILL
Journal:  Postgrad Med J       Date:  1965-02       Impact factor: 2.401

7.  HAPTOGLOBIN SYNTHESIS. I. IN VIVO STUDIES OF THE PRODUCTION OF HAPTOGLOBIN, FIBRINOGEN, AND GAMMA-GLOBULIN BY THE CANINE LIVER.

Authors:  C A ALPER; J H PETERS; A G BIRTCH; F H GARDNER
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

8.  [THE HEMOLYTIC SYNDROME IN ACUTE AND CHRONIC HEPATITIS].

Authors:  P G FRICK; J R SCHMID
Journal:  Klin Wochenschr       Date:  1965-03-15

9.  [STUDIES ON CHANGES IN THE BLOOD PICTURE IN LIVER CIRRHOSIS].

Authors:  H HUBER; N SHIRAKURA
Journal:  Blut       Date:  1965-05

10.  Differential ferrioxamine test in haemochromatosis and liver diseases.

Authors:  M Barry; G Cartei; S Sherlock
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.